This public procurement contract involves the delivery of diagnostic equipment for research and experimental purposes at the contracting authority's facilities. The specific items required are identified by catalog or reference numbers. The contracting authority does not allow alternative solutions
Contract awarded. Originally published 11 months ago.
No single supplier dominates the field.
In healthcare medical, INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE has awarded 28 contracts to 26 suppliers.
+20 more suppliers
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This public procurement contract involves the regular supply of medicinal products for parenteral administration containing the active substance tigecycline (ATC group J01AA12). These products are intended for the treatment of patients in approved indications according to the Summary of Product Char
This public procurement contract involves the ongoing supply of medical devices, specifically diagnostic strips for blood glucose testing. Suppliers are invited to provide these essential health products to support diabetes management. The total value of the contract is €5,250,000, and it is publish
This public procurement contract involves the repeated supply of specialized medical materials (SMM) in accordance with the current Medical Devices Act. The focus is on short-term catheter-based mechanical heart support systems necessary for treating patients at the buyer's facilities. The expected
This public procurement contract involves the repeated supply of specialized medical materials in accordance with the applicable medical device legislation. The focus is on balloon dilatation catheters that release sirolimus, which are essential for treating patients at the buyer's facilities. Suppl
Funding up to £3 million for human experimental medicine studies investigating the biological and psychological causes of gambling disorder development and recovery.
Apply for up to £26.25 million in MRC funding over 14 years to establish a centre of research excellence addressing complex health challenges.
Grants up to £200,000 available for early-stage, high-risk environmental research projects without requiring preliminary data, running for up to two years.
UKRI is funding empirical research to establish reliable estimates of the economic and social returns on R&D investments to guide public and private sector decision-making.
